Facebook
Twitter
Telegram
Report an ErrorEledon Pharmaceuticals Financial Statements 2011-2024 | ELDN
Annual Financial Statements Eledon Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
50.7 M | 33.4 M | 52.3 M | 9.72 M | - | - | - | - | - | - | - | - | - |
Shares |
24.6 M | 14.3 M | 14.8 M | 656 K | - | - | - | - | - | - | - | - | - |
Historical Prices |
2.06 | 2.34 | 3.53 | 16.1 | 10.1 | 86.9 | 66.1 | 133 | 1.03 K | 2.45 K | - | - | - |
Net Income |
-40.3 M | -88 M | -34.5 M | -24.7 M | -16 M | -14.1 M | -13.1 M | -38 M | -45.1 M | -23.3 M | -15.7 M | -9.65 M | - |
Revenue |
- | - | - | 120 K | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 120 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-43 M | -88.4 M | -36.9 M | -18.5 M | -16.1 M | -14.1 M | -13.1 M | -5.13 M | -45.3 M | -23.5 M | -15.7 M | -9.65 M | - |
Interest Expense |
2.67 M | 462 K | 7 K | 79 K | 40 K | -5 K | 5 K | -527 K | - | - | - | - | - |
EBITDA |
-43 M | -88.4 M | -36.9 M | -20 M | -12.1 M | -14 M | -13.1 M | -38 M | -45.2 M | -23.6 M | -15.7 M | -9.64 M | - |
Operating Expenses |
43 M | 88.4 M | 36.9 M | 17.8 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
12.7 M | 12.7 M | 13.1 M | 8.32 M | 6.06 M | 7.24 M | 11.1 M | 13.1 M | 12.6 M | 8.88 M | 3.55 M | 2.28 M | - |
All numbers in USD currency
Quarterly Income Statement Eledon Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
30 M | 24.2 M | 30 M | 24 M | 14.3 M | 13.8 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 14.8 M | 14.8 M | 14.8 M | 15.2 M | 1.11 M | 943 K | 959 K | 720 K | 721 K | 11.8 M | 9.43 M | 9.42 M | 9.42 M | 9.41 M | 7.75 M | 7.11 M | 6.94 M | 4.15 M | 414 K | 394 K | 81.3 K | 77.9 K | 22.6 M | 22.6 M | 22.5 M | 22.4 M | 22.4 M | 22.4 M | 2.36 M | 501 K | 495 K | 493 K | 493 K | - | - | - | - | - | - | - | - | - | - |
Net Income |
-10.3 M | - | -10.3 M | -9.58 M | -10.8 M | - | -10.5 M | -9.25 M | -9.86 M | - | -9.82 M | -7.38 M | -8.5 M | - | -6.14 M | -2.59 M | -8.18 M | - | -2.89 M | -4.09 M | -4.88 M | - | -3.5 M | -3.19 M | -2.81 M | - | -2.97 M | -6.66 M | -1.37 M | -3.74 M | -2.04 M | -1 M | -11.4 M | -11 M | -11.9 M | -8.96 M | -13.3 M | -6.21 M | -6.39 M | -5.85 M | -4.85 M | -5.52 M | -3.36 M | -4.44 M | -2.39 M | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.9 M | - | -11.2 M | -10.4 M | -11.1 M | - | -10.6 M | -9.28 M | -9.86 M | - | -10.5 M | -7.97 M | -9 M | - | -6.15 M | -2.59 M | -3.38 M | - | -2.92 M | -4.09 M | -4.88 M | - | -3.5 M | -3.19 M | -2.8 M | - | -2.96 M | -6.67 M | -1.38 M | -3.76 M | -1.62 M | -932 K | -11.5 M | -11.1 M | -11.9 M | -8.98 M | -13.3 M | -6.26 M | -6.42 M | -5.88 M | -4.89 M | -5.55 M | -3.36 M | -4.44 M | -2.39 M | - | - | - | - | - | - | - | - |
Interest Expense |
574 K | - | 849 K | 775 K | 338 K | - | 127 K | 36 K | -5 K | - | 3 K | -1 K | 5 K | - | 4 K | 5 K | 30 K | - | 27 K | -4 K | -6 K | - | 3 K | -11 K | -11 K | - | -5 K | 4 K | 11 K | - | -418 K | -70 K | - | - | - | - | - | - | 34 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | -10.6 M | -9.28 M | -9.86 M | - | -10.5 M | -7.97 M | -9 M | - | -6.14 M | -2.59 M | -3.38 M | - | -2.91 M | -4.08 M | -4.87 M | - | -3.49 M | -3.18 M | -2.79 M | - | -2.95 M | -6.65 M | -1.38 M | -3.76 M | -1.6 M | -912 K | -11.4 M | -11.1 M | -11.9 M | -8.96 M | -13.3 M | -6.26 M | -6.41 M | -5.87 M | -4.89 M | -5.55 M | -3.36 M | -4.44 M | -2.39 M | - | - | - | - | - | - | - | - |
Operating Expenses |
10.9 M | - | 11.2 M | 10.4 M | 11.1 M | - | 10.6 M | 9.28 M | 9.86 M | - | 10.5 M | 7.97 M | 9 M | - | 6.15 M | 2.59 M | 3.38 M | - | 2.92 M | 4.09 M | 4.88 M | - | 3.5 M | 3.19 M | 2.8 M | - | 2.96 M | 6.67 M | 1.38 M | - | 1.62 M | 932 K | 11.5 M | - | 11.9 M | 8.98 M | 13.3 M | - | 6.42 M | 5.88 M | 4.89 M | - | 3.36 M | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.46 M | - | 3.27 M | 3.15 M | 3 M | - | 3.15 M | 3.54 M | 3.22 M | - | 2.85 M | 3.73 M | 3.35 M | - | 3.73 M | 1.27 M | 1.73 M | - | 1.41 M | 1.79 M | 1.89 M | - | 1.85 M | 1.86 M | 1.7 M | - | 2.45 M | 6.13 M | 906 K | - | 564 K | 340 K | 3.55 M | - | 3.42 M | 3.13 M | 2.74 M | - | 3.6 M | 1.49 M | 1.34 M | - | 661 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency